Oncotarget

Research Papers:

FOXP3 and miR-155 cooperate to control the invasive potential of human breast cancer cells by down regulating ZEB2 independently of ZEB1

Cheryl Y. Brown, Sonia Dayan, Soon Wei Wong, Adrian Kaczmarek, Christopher M. Hope, Stephen M. Pederson, Victoria Arnet, Gregory J. Goodall, Darryl Russell, Timothy J. Sadlon and Simon C. Barry _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:27708-27727. https://doi.org/10.18632/oncotarget.25523

Metrics: PDF 1161 views  |   HTML 2475 views  |   ?  


Abstract

Cheryl Y. Brown1,2,*, Sonia Dayan2,3,*, Soon Wei Wong2, Adrian Kaczmarek4, Christopher M. Hope1, Stephen M. Pederson2, Victoria Arnet5, Gregory J. Goodall5, Darryl Russell4, Timothy J. Sadlon2,3 and Simon C. Barry1,2,3

1Discipline of Paediatrics, School of Medicine, Women’s and Children’s Hospital, University of Adelaide, Adelaide, 5006 SA, Australia

2Molecular Immunology, Robinson Research Institute, School of Medicine, University of Adelaide, Adelaide, 5005 SA, Australia

3Department of Gastroenterology, WCHN, Adelaide, 5006 SA, Australia

4Research Centre for Reproductive Health, Robinson Research Institute, School of Medicine, University of Adelaide, Adelaide, 5005 SA, Australia

5Gene Regulation Laboratory, Centre for Cancer Biology, University of South Australia, Adelaide, 5006 SA, Australia

*These authors contributed equally to this work

Correspondence to:

Simon C. Barry, email: simon.barry@adelaide.edu.au

Keywords: FOXP3; miR155; ZEB2; tumour suppressor; EMT

Received: December 23, 2017     Accepted: May 14, 2018     Published: June 12, 2018

ABSTRACT

Control of oncogenes, including ZEB1 and ZEB2, is a major checkpoint for preventing cancer, and loss of this control contributes to many cancers, including breast cancer. Thus tumour suppressors, such as FOXP3, which is mutated or lost in many cancer tissues, play an important role in maintaining normal tissue homeostasis. Here we show for the first time that ZEB2 is selectively down regulated by FOXP3 and also by the FOXP3 induced microRNA, miR-155. Interestingly, neither FOXP3 nor miR-155 directly altered the expression of ZEB1. In breast cancer cells repression of ZEB2, independently of ZEB1, resulted in reduced expression of a mesenchymal marker, Vimentin and reduced invasion. However, there was no de-repression of E-cadherin and migration was enhanced. Small interfering RNAs targeting ZEB2 suggest that this was a direct effect of ZEB2 and not FOXP3/miR-155. In normal human mammary epithelial cells, depletion of endogenous FOXP3 resulted in de-repression of ZEB2, accompanied by upregulated expression of vimentin, increased E-cadherin expression and cell morphological changes. We suggest that FOXP3 may help maintain normal breast epithelial characteristics through regulation of ZEB2, and loss of FOXP3 in breast cancer cells results in deregulation of ZEB2.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25523